Free Trial

OnKure Therapeutics (OKUR) Earnings Date, Estimates & Call Transcripts

OnKure Therapeutics logo
$3.00 -0.04 (-1.32%)
Closing price 04:00 PM Eastern
Extended Trading
$3.00 +0.00 (+0.17%)
As of 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OnKure Therapeutics Earnings Summary

Upcoming Q1
Earnings Date
May. 6Before Market OpensEstimated
Consensus EPS
(Mar. 10)
-$0.86
Actual EPS
(Mar. 10)
-$1.37 Missed By -$0.51

OnKure Therapeutics issued Q4 2024 earnings on March 10, 2025, reporting an EPS of -$1.37, which missed analysts' consensus estimates of -$0.86 by $0.51. With a trailing EPS of -$6.57, OnKure Therapeutics' earnings are expected to grow next year, from ($4.05) to ($3.41) per share.

Q4 2024 Earnings Resources

OKUR Upcoming Earnings

OnKure Therapeutics' next earnings date is estimated for Tuesday, May 6, 2025, based on past reporting schedules.

Get OnKure Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on OnKure Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

OKUR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
Remove Ads

OnKure Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$1.41-$1.41-$1.41
Q2 20251-$1.43-$1.43-$1.43
Q3 20251-$1.27-$1.27-$1.27
Q4 20251-$1.15-$1.15-$1.15
FY 20254($5.26)($5.26)($5.26)
Remove Ads

OnKure Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/6/2025
(Estimated)
--------
3/10/2025Q4 2024-$0.86-$1.37 -$0.51-$1.37--
11/7/2024Q3 2024-$0.97-$1.10 -$0.13-$1.10--
8/13/2024Q2 2024-$1.70-$1.60+$0.10-$1.60--
5/7/2024Q1 2024-$3.70-$2.50+$1.20-$2.50--
3/28/2024Q4 2023-$5.50-$7.00 -$1.50-$7.00--
11/13/2023Q3 2023-$6.00-$5.70+$0.30-$5.70--
8/10/2023Q2 2023-$5.50-$6.50 -$1.00-$6.50--
5/11/2023Q1 2023-$6.30-$6.00+$0.30-$6.00--

OnKure Therapeutics Earnings - Frequently Asked Questions

OnKure Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 6th, 2025 based off last year's report dates. Learn more on OKUR's earnings history.

In the previous quarter, OnKure Therapeutics (NASDAQ:OKUR) missed the analysts' consensus estimate of ($0.86) by $0.51 with a reported earnings per share (EPS) of ($1.37). Learn more on analysts' earnings estimate vs. OKUR's actual earnings.

OnKure Therapeutics (NASDAQ:OKUR) has a recorded net income of -$77.39 million. OKUR has generated -$6.57 earnings per share over the last four quarters.

OnKure Therapeutics's earnings are expected to grow from ($4.05) per share to ($3.41) per share in the next year.

More Earnings Resources from MarketBeat

Remove Ads


This page (NASDAQ:OKUR) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners